Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study

BACKGROUND: Allogeneic stem cell transplantation (allo-SCT) remains the only effective curative therapy for primary myelofibrosis. Utilization and efficacy of allo-SCT are limited by lethal complications, including engraftment failure, and acute (aGVHD) and chronic graft-versus-host disease (cGVHD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qingyuan, Xu, Na, Wang, Yu, Zhang, Xi, Liu, Limin, Zhou, Huifen, Wang, Hong, Zhang, Xiang, Tang, Xiaowen, Fu, Chengcheng, Miao, Miao, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818875/
https://www.ncbi.nlm.nih.gov/pubmed/35141151
http://dx.doi.org/10.3389/fonc.2021.792142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818875/
https://www.ncbi.nlm.nih.gov/pubmed/35141151
http://dx.doi.org/10.3389/fonc.2021.792142

Ejemplares similares